These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31659698)

  • 1. The diagnostic challenge of cardiomyopathies: When should we suspect cardiac amyloidosis?
    Gobbo M; Bender D; Mosto H; Sueiro H; Mocskos A; Tepper R; Carbajales J
    J Nucl Cardiol; 2020 Oct; 27(5):1844-1849. PubMed ID: 31659698
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac amyloidosis CT sign.
    Saba SG; Gannon MP; Majure DT; Rahmani N; Shah AB; Palestro CJ; Shah RD
    Clin Res Cardiol; 2021 Nov; 110(11):1841-1846. PubMed ID: 32661673
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cardiac amyloidosis. Diagnostic and prognostic value of Doppler echocardiography].
    Hernández A; Del Río A; Moya JL; Rayo I; Artigao R; Soler JM; Marín R; Jiménez AM
    Rev Port Cardiol; 1991 Jun; 10(6):525-8. PubMed ID: 1931112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Technetium TC 99m pyrophosphate myocardial scintigraphy in amyloidosis. Correlations with Doppler echocardiography].
    Fournier C; Grimon G; Rinaldi JP; Terral A; Boujon B; Adams A; Desgrez A; Blondeau M
    Arch Mal Coeur Vaiss; 1993 Jul; 86(7):1009-15. PubMed ID: 8291935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of (99m)Tc-DPD scintigraphy on discrimination of familial cardiac amyloidosis.
    Ferreira SG; Rocha AM; Moreira do Nascimento OJ; Mesquita CT
    Int J Cardiol; 2016 Jan; 203():885-7. PubMed ID: 26605689
    [No Abstract]   [Full Text] [Related]  

  • 6. A patient with cardiac amyloidosis presenting a rapid increase in technetium-99m-hydroxymethylene diphosphonate accumulation.
    Kobayashi T; Sekiya M; Fujiwara Y; Sumimoto T; Matsuoka H; Hamada M; Hiwada K
    Ann Nucl Med; 1993 Nov; 7(4):273-6. PubMed ID: 8292455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of myocardial amyloid deposits in cardiac amyloidosis by Tc-99m pyrophosphate myocardial SPECT: implication for medical treatment.
    Casset-Senon D; Secchi V; Arbeille P; Cosnay P
    Clin Nucl Med; 2005 Jul; 30(7):496-7. PubMed ID: 15965328
    [No Abstract]   [Full Text] [Related]  

  • 8. Tc-99m(V) DMSA uptake in cardiac amyloidosis.
    Ohta H; Okada T; Furukawa Y; Yamamoto K; Miyaki Y; Shizuki K; Kotoura H; Endo K; Konishi J; Ohshima C
    Clin Nucl Med; 1991 Sep; 16(9):673-5. PubMed ID: 1657486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboembolic complications in cardiac amyloidosis detected by transesophageal echocardiography.
    Willens HJ; Levy R; Kessler KM
    Am Heart J; 1995 Feb; 129(2):405-6. PubMed ID: 7832118
    [No Abstract]   [Full Text] [Related]  

  • 10. Focal fibrosis in the left ventricle of subjects with cardiac amyloidosis evaluated by multislice computed tomography.
    Mikami Y; Funabashi N; Kijima T; Uehara M; Shiina Y; Lee K; Nakayama T; Daimon M; Kuroda N; Kobayashi Y; Takano H; Komuro I
    Int J Cardiol; 2007 Oct; 122(1):72-5. PubMed ID: 17234285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac Amyloidosis Presenting as Severe Mitral Regurgitation.
    Ammar KA; Khandheria BK; Bajwa T; Port SC; Allaqaband S; Jain R; Neitzel G; Tajik AJ
    JACC Cardiovasc Imaging; 2016 Aug; 9(8):1003-6. PubMed ID: 27344421
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cardiac amyloidosis in plasmacytomas].
    Hoyer C; Weidemann F; Angermann CE
    Dtsch Med Wochenschr; 2008 Mar; 133(13):631-2. PubMed ID: 18351505
    [No Abstract]   [Full Text] [Related]  

  • 13. Diffuse Hepatosplenic 99mTc-Pyrophosphate Activity Caused by Amyloidosis.
    Ren J; Ren C; Huo L; Li F; Zhang S
    Clin Nucl Med; 2020 Mar; 45(3):246-247. PubMed ID: 31977456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac amyloidosis: an unusual cause of low flow-low gradient aortic stenosis with preserved ejection fraction.
    Haloui F; Salaun E; Maysou L; Dehaene A; Habib G
    Eur Heart J Cardiovasc Imaging; 2016 Apr; 17(4):383. PubMed ID: 26825321
    [No Abstract]   [Full Text] [Related]  

  • 15. (123)I-Labelled metaiodobenzylguanidine for the evaluation of cardiac sympathetic denervation in early stage amyloidosis.
    Noordzij W; Glaudemans AW; van Rheenen RW; Hazenberg BP; Tio RA; Dierckx RA; Slart RH
    Eur J Nucl Med Mol Imaging; 2012 Oct; 39(10):1609-17. PubMed ID: 22806059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac amyloidosis secondary to multiple myeloma detected by echocardiography].
    Iglesias FJ; Wong A; Carrasco F; De Bernard C; Nuñez P
    Rev Med Panama; 1994 Sep; 19(3):147-53. PubMed ID: 7746897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cardiac amyloidosis with two and three-dimensional echocardiography, anatomo-echocardiographic correlation and biopsy.
    Espinola-Zavaleta N; Hernández-López JE; Aranda-Fraustro A; Barragán-García O
    Arch Cardiol Mex; 2016; 86(2):178-9. PubMed ID: 26778844
    [No Abstract]   [Full Text] [Related]  

  • 18. A simple case of heart failure? Isolated cardiac amyloidosis.
    Shahid A; Javed F; Renton B
    Br J Hosp Med (Lond); 2019 Dec; 80(12):735. PubMed ID: 31822183
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of relative sensitivities of noninvasive tests for cardiac amyloidosis in documented cardiac amyloidosis.
    Simons M; Isner JM
    Am J Cardiol; 1992 Feb; 69(4):425-7. PubMed ID: 1734663
    [No Abstract]   [Full Text] [Related]  

  • 20. Advanced Nuclear Medicine and Molecular Imaging in the Diagnosis of Cardiomyopathy.
    Yang M; Arsanjani R; Roarke MC
    AJR Am J Roentgenol; 2020 Nov; 215(5):1208-1217. PubMed ID: 32901569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.